This document describes a process of producing gel microparticles, which are consistent in size and morphology. Through the process of coacervation, large volumes of gel microparticle slurry can be produced by scaling up reactor vessel size. Particles can be repeatedly dehydrated and rehydrated in accordance to their environment, allowing for the storage of particles in a non-solvent such as ethanol. Gel slurries exhibit a Bingham plastic behavior in which the slurry behaves as a solid at shear stresses that are below a critical value. Upon reaching the critical shear stress, the slurry undergoes a rapid decrease in viscosity and behaves as a liquid. The rheological behavior of these slurries can be adjusted by changing the compaction processes such as centrifugation force to alter the yield-stress. The narrower distribution and reduced size of these particles allows for an increase in FRESH printing fidelity.

Disclosed herein are matrices, compositions and methods of making matrices. The matrix comprises a biomolecule and the matrix is a dried, cross-linked foam. The matrix is not lyophilized. The method comprises foaming the composition, crosslinking the composition and drying the composition. Matrices disclosed herein are useful as wound dressings and treating wounds.

A composition includes a cartilage component for regeneration of cartilage and a manufacturing method therefor. A composition for regeneration of cartilage, in which a micronized cartilage powder is physically mixed with a biocompatible polymer or a chemically crosslinked biocompatible polymer. When applied, the composition can increase morphological retention and ease of use at cartilage injury sites.

A modified collagen fiber preparation method and application are provided. The modified collagen fiber is prepared by modifying a collagen fiber with a plant tannin; and a method of the preparation includes: mixing the plant tannin with the collagen fiber in a liquid environment with a pH of 5 to 8 to allow a reaction, and washing and drying a product. In the present disclosure, a plant tannin rich in phenolic hydroxyl can be combined with a collagen fiber in various ways such as multi-point hydrogen bonding and hydrophobic bonding, such that the plant tannin structure is introduced into a natural multi-layer micro/nano-structure of the collagen fiber; and due to a large number of phenolic hydroxyl structures in the plant tannin, the collagen fiber introduced with the plant tannin structure shows improved compatibility with a waterborne resin, and can produce strong hydrogen bonding with polar groups in the waterborne resin.

The present invention relates to a method of making biopolymer including but not limited to bio plastic from animal by-products, more specifically from poultry feathers wherein the method of making a biopolymer comprises the steps: i) i) pre-treatment of native feathers; ii) extraction of keratin protein from pre-treated feathers in the presence of reducing agent; iii) polymerization by blending keratin protein with one or more plasticizer, one or more additive and one or more cross-linking agent, optionally in presence of at least one alkali hydroxide to obtain a polymer compound using one or more thermal processing techniques at a temperature in the range of 60° C. to 150° C.; and iv) applying pressure and subjecting the polymer compound to thermal processing at a temperature in the range of 100° C. to 220° C. in presence of at least one or more excipients.

Described herein are methods of preparing protein scaffolds that can include the step of crosslinking protein fibers in the vapor phase of a natural aldehyde, such as cinnamaldehyde or vanillin or a solution thereof. Also described herein are protein scaffolds that can be prepared by a method that can include the step of crosslinking protein fibers in the vapor phase of a natural aldehyde solution, such as cinnamaldehyde or vanillin or a solution thereof.

The invention relates to a gel comprising a first gelatin component and a second gelatin component in an aqueous medium, wherein the first gelatin component comprises gelatin particles comprising chemical cross-links and dehydrothermal cross-links; and the second gelatin component comprises a dissolved gelatin comprising chemical cross-links and at least one polysaccharide.

Disclosed herein are matrices, compositions and methods of making matrices. The matrix comprises a biomolecule and the matrix is a dried, cross-linked foam. The matrix is not lyophilized. The method comprises foaming the composition, crosslinking the composition and drying the composition. Matrices disclosed herein are useful as wound dressings and treating wounds.

A modified collagen fiber preparation method and application are provided. The modified collagen fiber is prepared by modifying a collagen fiber with a plant tannin; and a method of the preparation includes: mixing the plant tannin with the collagen fiber in a liquid environment with a pH of 5 to 8 to allow a reaction, and washing and drying a product. In the present disclosure, a plant tannin rich in phenolic hydroxyl can be combined with a collagen fiber in various ways such as multi-point hydrogen bonding and hydrophobic bonding, such that the plant tannin structure is introduced into a natural multi-layer micro/nano-structure of the collagen fiber; and due to a large number of phenolic hydroxyl structures in the plant tannin, the collagen fiber introduced with the plant tannin structure shows improved compatibility with a waterborne resin, and can produce strong hydrogen bonding with polar groups in the waterborne resin.

Embodiments herein described provide devices for identifying and collecting rare cells or cells which occur at low frequency in the body of a subject, such as, antigen-specific cells or disease-specific cells. More specifically, the devices are useful for trapping immune cells and the devices contain a physiologically-compatible porous polymer scaffold, a plurality of antigens, and an immune cell-recruiting agent, wherein the plurality of antigens and the immune cell recruiting agent attract and trap the immune cell in the device. Also provided are pharmaceutical compositions, kits, and packages containing such devices. Additional embodiments relate to methods for making the devices, compositions, and kits/packages. Further embodiments relate to methods for using the devices, compositions, and/or kits in the diagnosis or therapy of diseases such as autoimmune diseases or cancers.